Aspects of pharmacokinetics of Cidipol drug while rectal and dermal application as basis for its clinical use

Abstract

Cidipol is a combination drug in the form of a solution of chlorine­brown aldehyde in dimexide and polyethylene glycol (PEG-400). Objective — to study the pharmacokinetics of Сidipol drug while rectal and dermal application, as also to evaluate the features of its metabolism in the body of animals. Materials and methods. Experiments were carried out on rabbits of the chinchilla breed (six animals for each route of administration) in which blood plasma was examined by gas chromatography (GC) at certain intervals after the administration of the drug. Results and discussion. The pharmacokinetic profile of the drug during external application to animals was characterized by the presence of a half-hour lag (hidden) period. Then slow absorption of ciminal with a maximum accumulation (Tmax) of 3 hours, its slow elimination from the body of an animal with a half-life (T0.5) of 5.3 hours and elimination coefficient (Kel) 0.13 were recorded. The volume of distribution of ciminal (Vp) with external application of Cidipol is 10 500 ml. When administered rectally, its pharmacokinetic profile is characterized by a slow absorption of ciminal with a semi­absorption period of 1.1 hours, Tmax = 2.5 hours and a rather slow elimination from animals’ body (T0.5 = 5.1 hours, Kel = 0.13). Vp of a ciminal makes up 3600 ml, which testifies to its ability to accumulate in tissues in higher concentration than in blood. Conclusions. It is established that the time of transmembrane diffusion of PEG-400 and the time of semisuscitation of the ciminal are almost similar, that is, overcoming the membrane barriers of ciminal occurs in the local environment of its solvents, and the preparation Cidipol with rectal administration and application of the skin is absorbed with solvents as a whole. Accumulated Vр of the drug in the skin and on the mucous membrane of the rectum are evaluated as positive for the implementation of the pharmacological effect. The results obtained provide a good reason for the clinical use of Cidipol in dermatological and cosmetological practice, as well as in pathological processes in the rectum.

Authors and Affiliations

L. V. Ivanov, V. G. Kravchenko

Keywords

Related Articles

Justification of antibacterial therapy for atopic dermatitis

Skin is the largest organ of the human body, colonized by millions of microorganisms, most of which are harmless and even beneficial to their host. Congenital and acquired skin immunity can adapt to the skin’s microbiota...

Impact of clinical course of epidermolysis bullosis on quality of life of patients in Ukraine

Objective — to determine the impact of the severity of epidermolysis bullosa (EB) on the quality of life (QL) of patients with this disease. Materials and methods. The work was performed at the Department of Dermatology...

Case of advanced stage of foot onychomycosis

An overview of statistics on fungal infections in the world, including Ukraine is presented. The localization of mycotic lesions, their causes, as well as associated diseases are considered. The clinic of lesions of myco...

Dynamics of clinical manifestations and blood serum content of specific cytokines in patients with rosacea treated by means of integrated therapy

Objective — to determine and analyze the dynamics of clinical manifestations and blood serum content of specific cytokines in patients with rosacea treated by means of integrated therapy. Materials and methods. The stud...

Features of cortisol secretion in adult patients with atopic dermatitis

Оbjective — to determine features of basal cortisol secretion dynamics in atopic dermatitis (AD) patients depending on pathogenesis variant and age of the disease onset. Materials and methods. 63 adult patients with ato...

Download PDF file
  • EP ID EP581083
  • DOI 10.30978/UJDVK2019-1-78
  • Views 114
  • Downloads 0

How To Cite

L. V. Ivanov, V. G. Kravchenko (2019). Aspects of pharmacokinetics of Cidipol drug while rectal and dermal application as basis for its clinical use. Український журнал дерматології, венерології, косметології, 0(1), 78-83. https://europub.co.uk./articles/-A-581083